🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Phase 1, First-In-Human, Randomized, Double-Blind, Placebo-Controlled Mul...
Status
Completed
Location
Nucleus Network Pty Ltd
Start Date
2025-05-29
Trial ID
NCT06981299
Treatments Being Tested
This multi-center, randomized, double-blinded, placebo-controlled, dose-ran...
Status
Completed
Location
Praxis Research Site
Start Date
2021-10-14
Trial ID
NCT05021991
Treatments Being Tested
This study will determine whether the negative effects of combined oral con...
Status
Completed
Location
Women's Health and Exercise Laboratories, The Pennsylvania State University
Start Date
2015-01
Trial ID
NCT02367833
Treatments Being Tested
Compare the safety and efficacy of two different oral vapendavir doses with...
Status
Recruiting
Location
Velocity Clinical Research - Mobile
Start Date
2026-05-01
Trial ID
NCT07610395
Treatments Being Tested
SRT2104 is a potent small molecule activator of SIRT1 that has been found t...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-12-09
Trial ID
NCT01014117
Perioperative Myocardial Infarction (PMI) is a major contributor to periope...
Status
Withdrawn
Location
St. Paul's Hospital
Start Date
2020-09-01
Trial ID
NCT04139655
Treatments Being Tested
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
A Phase 1 study will test the safety, tolerability and pharmacokinetics of ...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-07-26
Trial ID
NCT03096756
This study is the first administration of GSK2982772 in humans. The study w...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-06
Trial ID
NCT02302404
Treatments Being Tested
GSK1120212 is a potent and highly selective inhibitor of MEK phosphorylatio...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-08
Trial ID
NCT01231581
Treatments Being Tested